Is breast cancer HER2-positive curable?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
The so-called racial gap in breast cancer care has long been suggested by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. Researchers claim financial factors such as economic and social class or access to insurance alone can't e....
Please visit an ENT surgeon. Hoarseness of voice for such a long period could be because of a number of reasons like: overuse of vocal cords-singing/yelling, upper respiratory tract infection causing inflammation of vocal cords, the tumorous growth of the cord. Bronchoscopy would be the best diagnos....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
كُتب بواسطة:Dr. Nitika Sharma - BDS
تمت مراجعته من قبل:Dr. Rakesh Kumar - MBBS, MS
Kanishka Pandey
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells.
HER2-positive breast cancers are known to be more aggressive than HER2-negative breast cancers and are more likely to recur than HER2-negative breast cancer. The recurrence usually takes place within five years of treatment.
The good news is that recurrence is less likely these days than ever before. This is largely due to the latest targeted treatments. In fact, most people treated for early stage HER2-positive breast cancer don’t relapse. If your breast cancer is HR-positive, hormonal therapy may help reduce the risk of recurrence.
Your treatment plan will probably include a combination of therapies such as:
Targeted treatments (medicines like Herceptin, Kadcyla, Perjeta and Tykerb are used in this process) Once the treatment ends, you’ll still need periodic testing for signs of recurrence.